Accessibility Menu
Sanuwave Health logo

Sanuwave Health(NASDAQ) SNWV

Current Price$5.96
Market Cap$50.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2009)-100%
5 Year-90%
1 Year-84%
1 Month-31%
Sanuwave Health last closing stock price
MetricPriceDate
Last closeUSD 5.932026-07-24
Sanuwave Health stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-7.2%USD 6.392026-07-17
1 month-30.81%USD 8.572026-06-24
3 month-68.29%USD 18.702026-04-24
Year to date-80.13%USD 29.842025-12-31
1 year-83.87%USD 36.762025-07-24
3 year-16.77%USD 7.132023-07-25
5 year-89.73%USD 57.752021-07-23
Since inception-99.7%USD 1,968.732009-09-30

Sanuwave Health Financials at a Glance

Market Cap

$50.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$44.33M

Net Income (TTM)

$16.05M

EPS (TTM)

$0.33

P/E Ratio

18.14

Dividend

$0.00

Beta (Volatility)

4.46 (High)

Price

$5.96

Volume

109,460.894

Open

$5.90

Previous Close

$5.93

Daily Range

$5.82 - $6.16

52-Week Range

$5.77 - $46.59

Estimated Earnings Date

Aug 14, 2026

SNWV News

Foolcom-Featured.png

Sanuwave (SNWV) Q2 Revenue Jumps 42%

Motley Fool Markets TeamAug 8, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Sanuwave Health

SANUWAVE helps treat hard-to-heal wounds using sound waves and ultrasound. Its main products support hospitals and clinics treating chronic wounds, like diabetic foot ulcers. These devices aim to speed up healing and reduce pain for patients.

Products and Services

  • UltraMIST Consumables: Single-use applicators for UltraMIST; accounted for approximately 58% of total revenues in 2025; recurring revenue stream; sold in cases of 12.
  • Extended Warranties: Service contracts for UltraMIST systems; provides ongoing support for healthcare providers.
  • dermaPACE Device: Shock wave device for diabetic foot ulcers; legacy product with limited current sales.
  • orthoPACE System: Device for treating tendon injuries and bone fractures; niche orthopedic use.

Growth and Expansion

  • Expanded reseller sales channel in 2025, with resellers accounting for 34% of system sales.
  • Sold and discontinued PACE product line in 2025 to focus on wound care.
  • Sold patent portfolio in 2025, generating a $5 million gain.
  • Moved headquarters to a larger facility in Eden Prairie, Minnesota, in 2025.
  • Secured new $23 million term loan and $5 million credit facility with JPMorgan Chase in 2025.

What Makes SANUWAVE Stand Out

SANUWAVE’s business model relies on recurring sales of consumables, creating steady revenue. Its FDA-cleared technology targets a large U.S. wound care market. The company maintains direct and distributor sales channels, with a focus on regulatory compliance and intellectual property protection.

Five Things You Need to Know

  • Revenue was $44.1 million in 2025, up 35% from 2024.
  • Consumables made up 58% of 2025 revenue, with 24% unit growth year-over-year.
  • Gross margin reached 77% in 2025, up from 75% in 2024.
  • Net income was $11.8 million in 2025, reversing a $33.1 million loss in 2024.
  • International sales were less than 1% of total revenue in 2025.

Bottom Line

SANUWAVE has shifted to focus on wound care, recurring consumable sales, and operational efficiency. The company’s evolution reflects adaptability and a targeted approach in a competitive healthcare market.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

55

CEO

Morgan C. Frank

Website

www.sanuwave.com

Headquarters

Eden Prairie, MN 55344, US

SNWV Financials

Key Financial Metrics (TTM)

Gross Margin

75.68%

Operating Margin

6.40%

Net Income Margin

36.21%

Return on Equity

-450.56%

Return on Capital

20.11%

Return on Assets

43.26%

Earnings Yield

5.51%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$50.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

8.60M

Volume

109.46K

Avg. Volume

207.68K

Financials (TTM)

Gross Profit

$33.55M

Operating Income

$2.84M

EBITDA

$22.67M

Operating Cash Flow

$5.79M

Capital Expenditure

$73.00K

Free Cash Flow

$5.86M

Cash & ST Invst.

$10.78M

Total Debt

$22.16M

Sanuwave Health Performance Analysis

Sanuwave Health annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 16,742,00028.7%
20232023-12-31USD 20,398,00021.8%
20242024-12-31USD 32,634,00060.0%
20252025-12-31USD 44,051,00035.0%
Sanuwave Health sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-308.8%
Q32025-09-3012.7%
Q42025-12-3114.3%
Q12026-03-31-26.5%
Sanuwave Health annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -7.02-64.4%
20232023-12-31USD -12.1973.6%
20242024-12-31USD -7.41-39.2%
20252025-12-31USD 0.41N/A
Sanuwave Health sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30101.1%
Q32025-09-3015815.5%
Q42025-12-31-97.8%
Q12026-03-31-788.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$9.62M

+3.0%

Gross Profit

$7.19M

-2.7%

Gross Margin

74.70%

N/A

Market Cap

$50.99MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$927.13K

N/A

Employees

55

N/A

Net Income

-$1.44M

+74.6%

EBITDA

-$581.00K

+83.6%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$10.78M

+26.8%

Total Debt

$22.16M

-17.5%

Accounts Receivable

$6.00M

+55.2%

Inventory

$5.90M

+8.2%

Long Term Debt

$16.28M

+2766.0%

Short Term Debt

$5.89M

-77.6%

Return on Assets

43.26%

N/A

Return on Invested Capital

15.09%

N/A

Free Cash Flow

$308.00K

+118.3%

Operating Cash Flow

$397.00K

+126.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NNOXNano-X Imaging Ltd.
$0.90-7.97%
OMOutset Medical, Inc.
$4.04-4.49%
HSDTSolana Company
$1.63-4.12%
IMRXImmuneering Corporation
$4.32-1.59%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About SNWV

What is the current price of Sanuwave Health?

Sanuwave Health is trading at $5.93 per share.

What is the 52-week range for Sanuwave Health?

Over the past 52 weeks, Sanuwave Health has traded between $5.77 and $46.59.

How much debt does Sanuwave Health have?

As of the most recent reporting period, Sanuwave Health reported total debt of $22.16M.

How much cash does Sanuwave Health have on hand?

Sanuwave Health reported $10.78M in cash and cash equivalents in its most recent financial results.

What is Sanuwave Health’s dividend yield?

Sanuwave Health does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services